Stocktoria
Revium Rx. RVRC
OTC · OOTC · stock · Pharmaceutical Preparations · website · IPO 2001-08-22
Revium Rx. (RVRC) earns a Piotroski F-score of 0/9 (weak financial health). It does not currently pay a dividend.
0/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Price from month-end closes (Yahoo) — for reference, not real-time.
Return on equity-195.5%
How it ranks in Manufacturing · percentile among 1829 companies
Piotroski Fstronger than 0%
Return on equitystronger than 9%
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 0/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Detailed pages
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| RVRC | Revium Rx. | 0/9 | — | — | — |
| JNJ | JOHNSON & JOHNSON | 4/9 | — | 22.9 | +6% |
| LLY | ELI LILLY & Co | 7/9 | — | 55.1 | +44.7% |
| MRK | Merck & Co., Inc. | 4/9 | — | 17.4 | +1.3% |
| PFE | PFIZER INC | 4/9 | — | 17.8 | -1.6% |
| ABBV | AbbVie Inc. | 7/9 | -0.34 | 105.9 | +8.6% |
| BMY | BRISTOL MYERS SQUIBB CO | 7/9 | — | 16.7 | -0.2% |
FAQ
Is RVRC financially healthy?
Revium Rx.'s Piotroski F-score is 0/9 (8–9 is excellent, 0–3 weak).
Does RVRC pay a dividend?
No, Revium Rx. does not currently pay a dividend.
How profitable is RVRC?
In FY2025, Revium Rx. had a return on equity of -195.5%.
Source: SEC EDGAR filings · CIK 0001839140 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.